BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38216011)

  • 1. VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production.
    Miao J; Tu Y; Jiang J; Ren R; Wu Q; Liang H; Wang T; Lin B; Wu J; Pan Y; Wang X; Jin H
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129357. PubMed ID: 38216011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
    Chen D; Ye Z; Wang C; Wang Q; Wang H; Kuek V; Wang Z; Qiu H; Yuan J; Kenny J; Yang F; He J; Liu Y; Wang G; Zhang M; Zhang G; Wang J; Chen P; Xu J
    Pharmacol Res; 2020 Sep; 159():104944. PubMed ID: 32454224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-
    Wong P; Lv Z; Li J; Wei Q; Xu L; Fang B; Luo Y; He M
    Oxid Med Cell Longev; 2022; 2022():5982014. PubMed ID: 36388169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
    Guo J; Ren R; Guo Z; Sun K; He J; Shao J; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109820. PubMed ID: 36758295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
    Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
    J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
    Kanzaki H; Shinohara F; Kajiya M; Kodama T
    J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2/ROS/NF-κB pathway.
    Liu Y; Li TQ; Bai J; Liu WL; Wang ZR; Feng C; Pu LL; Wang XX; Liu H
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166977. PubMed ID: 38065271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.
    Qin Y; Song D; Liao S; Chen J; Xu M; Su Y; Lian H; Peng H; Wei L; Chen K; Xu J; Zhao J; Liu Q
    Biomed Pharmacother; 2023 Apr; 160():114347. PubMed ID: 36746095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis.
    Xu Y; Song D; Su Y; Chen J; Wu L; Lian H; Hai N; Li J; Jiang J; Zhao J; Xu J; Liu Q
    Biomed Pharmacother; 2023 Mar; 159():114101. PubMed ID: 36640671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.
    Xu Y; Song D; Lin X; Peng H; Su Y; Liang J; Hai N; Zhao J; Liu Q
    Free Radic Biol Med; 2023 Feb; 196():121-132. PubMed ID: 36649902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
    Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
    Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation.
    Reziwan K; Sun D; Zhang B; Zhao Z
    Cell Biochem Funct; 2019 Jun; 37(4):256-265. PubMed ID: 31017694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.
    Yamaguchi Y; Kanzaki H; Katsumata Y; Itohiya K; Fukaya S; Miyamoto Y; Narimiya T; Wada S; Nakamura Y
    J Cell Mol Med; 2018 Feb; 22(2):1138-1147. PubMed ID: 29063666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling
    Huang Z; Jiang Z; Zheng Z; Zhang X; Wei X; Chen J; Zhao F
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1068-1079. PubMed ID: 35929596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
    Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q
    Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urolithin B suppresses osteoclastogenesis via inhibiting RANKL-induced signalling pathways and attenuating ROS activities.
    Qu Z; An H; Feng M; Huang W; Wang D; Zhang Z; Yan L
    J Cell Mol Med; 2022 Aug; 26(16):4428-4439. PubMed ID: 35781786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response.
    Xue P; Hu X; Chang E; Wang L; Chen M; Wu TH; Lee DJ; Foster BL; Tseng HC; Ko CC
    Exp Mol Med; 2021 Apr; 53(4):667-680. PubMed ID: 33864025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.
    Gong W; Liu M; Zhang Q; Zhang Q; Wang Y; Zhao Q; Xiang L; Zheng C; Zhang Q; Qin L
    Oxid Med Cell Longev; 2022; 2022():5410377. PubMed ID: 35585885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.